US Patent Issued to Octave Bioscience, 1nc. on Nov. 18 for "Biomarkers for predicting multiple sclerosis disease activity" (California, Washington Inventors)

ALEXANDRIA, Va., Nov. 18 -- United States Patent no. 12,474,336, issued on Nov. 18, was assigned to Octave Bioscience, 1nc. (Menlo Park, Calif.).

"Biomarkers for predicting multiple sclerosis disease activity" was invented by Michael Justin Becich (San Francisco), Victor Michael Gehman (Burlingame, Calif.), Ferhan Qureshi (Fremont, Calif.), William A. Hagstrom (Santa Barbara, Calif.), Amal Kamal Katrib (Seattle) and Fatima Rubio da Costa (Mountain View, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are methods for analzying quantitative expression values of biomarkers of a biomarker panel for determining disease activity in a human subject. Further disclosed herein are kits for measu...